All News Ludwig Enterprises, Inc.

Equities

LUDG

US54973P4019

Market Closed - OTC Markets Other stock markets 09:54:25 2024-07-08 am EDT			5-day change	1st Jan Change
0.1779 ^USD	+4.66%		-3.26%	+31.29%

Jul. 09	Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer	CI
May. 20	Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer	Jul. 09	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 20	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024	Mar. 19	AQ
Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	Mar. 19	CI
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers	Mar. 06	AQ
Ludwig Enterprises Inc. Announces Patent Filing for Breakthrough in Identifying Mrna Genes Associated with Certain Cancers	Mar. 06	CI
Ludwig Enterprises, Inc. announced that it has received $0.04 million in funding	Feb. 11	CI
Ludus Enterprises, Inc. Receives Continuing Review Approval on Planned Clinical Study from Advarra IRB, Columbia, MD	Jan. 31	CI
Ludwig Enterprises, Inc. Announces Executive Changes	Dec. 01	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Ludwig Enterprises, Inc. Appoints Scott Silverman as Chief Financial Officer	Nov. 16	CI
Ludwig Enterprises, Inc. Announces Marvin S. Hausman as Chief Executive Officer	23-09-19	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-21	CI
Ludwig Enterprises Announces Launches of New Nutraceutical and Strategic Marketing Plan	23-04-25	CI
Ludwig Enterprises Launches Nugenea, Groundbreaking Nutraceutical to Fight Inflammation	23-04-12	CI
Ludwig Enterprises, Inc. Auditor Raises 'Going Concern' Doubt	23-02-14	CI
Ludwig Enterprises, Inc. Receives Institutional Review Board Approval on Bladder Cancer Study	23-01-03	CI
Precision Genomics (a Ludwig Company) Will Break Major Medical News at a Presentation for LD Micro Tuesday, Oct. 25th, 2022	22-10-24	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Ludwig Enterprises, Inc.

Equities

LUDG

US54973P4019

All News

Filters